The Scientist

» industry and cell & molecular biology

Most Recent

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: Damage Patroller

Damage Patroller

By | October 1, 2017

Stephen Elledge has built a career studying how eukaryotic cells maintain genomic integrity.

0 Comments

The 38-year-old synthetic biologist comes from a long line of tinkerers and engineers.

0 Comments

image: Live Cell Extractions

Live Cell Extractions

By | October 1, 2017

Nanostraws that collect specimens from cells without killing them allow for repeated sampling.

1 Comment

image: Microglia Turnover in the Human Brain

Microglia Turnover in the Human Brain

By | October 1, 2017

Researchers find that about a quarter of the immune cells are replaced every year.

1 Comment

Pauses may help cells fine-tune gene expression.

0 Comments

image: Infographic: Macrophages Around the Body

Infographic: Macrophages Around the Body

By | October 1, 2017

In addition to circulating in the blood as immune sentinels, macrophages play specialized roles in different organs around the body.

0 Comments

image: Macrophages Are the Ultimate Multitaskers

Macrophages Are the Ultimate Multitaskers

By | October 1, 2017

From guiding branching neurons in the developing brain to maintaining a healthy heartbeat, there seems to be no job that the immune cells can’t tackle.

0 Comments

image: Opinion: Tales from the Nonacademic Career Path

Opinion: Tales from the Nonacademic Career Path

By | September 3, 2017

Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.

0 Comments

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials